Related Experiment Video
Updated: Jan 10, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Coumarin-based fluorescent ligands target mitochondrial G-quadruplexes for liver cancer growth suppression
1Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen 518060, China.
Abstract:
Natural coumarins are important scaffolds in drug development due to their diverse biological activities. This study investigated coumarin-derived fluorescent ligands targeting mitochondrial DNA G-quadruplexes (mtG4s), which are emerging therapeutic targets in cancer research. Six coumarin derivatives (X-1 to X-6) were synthesized, with X-1 showing the strongest stabilizing ability (ΔTm = 34 °C) and best fluorescence properties for mtG4s. X-1 may not only serve as a near-infrared (NIR) fluorescent tool for studying mtG4 dynamics but also induce mitochondrial dysfunctions in liver cancer cells, demonstrating potent anticancer activity. These findings highlighted the potential of mtG4-targeted strategies for cancer therapy, combining diagnostic and therapeutic functions. The study supported the development of coumarin-based ligands as dual-purpose agents for cancer therapy.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
09:00An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...